Merck to acquire biopharma CDMO Exelead for $780m
The acquisition of Exelead, a full-service contract development and manufacturing organisation focused on Lipid Nanoparticle formulations, is expected…
Novartis to acquire Gyroscope Therapeutics for up to $1.5bn
23 Dec 21The acquisition will enable Novartis to add Gyroscope’s investigational gene therapy, GT005, to its portfolio
Sanofi to buy immuno-oncology firm Amunix Pharmaceuticals for $1.2bn
22 Dec 21The acquisition of Amunix will enable Sanofi to discover and develop advanced T-cell engagers (TCE) and cytokine medicines…
CSL agrees to buy Swiss firm Vifor Pharma for $11.7bn
15 Dec 21The acquisition is expected to expand CSL’s offering across a portfolio focused on renal disease, and iron deficiency…
Pfizer to acquire Arena Pharmaceuticals in $6.7bn deal
14 Dec 21Arena is a clinical-stage pharmaceutical company involved in the development of potential therapies for the treatment of several…
Lilly, Foghorn collaborate on developing novel oncology drugs
14 Dec 21The partnership will jointly develop and commercialise Foghorn's selective BRM programme, and three additional discovery programmes
Thermo Fisher closes acquisition of clinical research firm PPD for $17.4bn
09 Dec 21The acquisition will enable Thermo Fisher to provide a complete suite of discovery, clinical trial logistics, development and…
Alvotech to go public through $2.25bn merger with SPAC Oaktree
08 Dec 21The transaction will enable Alvotech to further invest in its platform and portfolio, and support its goal of…
Sanofi to buy Origimm Biotechnology for vaccine candidate to treat acne
02 Dec 21Origimm is engaged in discovering virulent skin microbiome components and antigens from bacteria that cause skin disease, including…
Essential Pharma closes two deals with UK-based Rosemont
26 Nov 21With the divestments of UK oral liquid products, Essential Pharma expects to streamline its portfolio and advance its…